This dataset contains information related to genetic associations with various diseases across different populations. Each entry highlights a specific gene, the associated disease, and details from studies assessing the relationship between them, including the type of methodology used, the strength of association, and the year of study.
| Gene | Disease | Population | Study Title | Year | Association Strength | Methodology |
|---|---|---|---|---|---|---|
| BRCA1 | Breast Cancer | European | BRCA1 mutations in breast cancer risk | 2020 | Strong | GWAS |
| BRCA2 | Breast Cancer | European | BRCA2 mutations linked to familial breast cancer | 2021 | Strong | Linkage Analysis |
| APOE | Alzheimer's Disease | Caucasian | APOE genotype and Alzheimer's disease | 1993 | Moderate | Case-Control Study |
| TP53 | Lung Cancer | Asian | TP53 mutations in lung cancer risk | 2019 | Strong | Next-Gen Sequencing |
| LRRK2 | Parkinson's Disease | Ashkenazi Jewish | Genetic risk factors for Parkinson's disease | 2017 | Moderate | Family-Based Study |
| FTO | Obesity | European | FTO gene variants and obesity in childhood | 2007 | Moderate | Meta-Analysis |
| CFTR | Cystic Fibrosis | Caucasian | CFTR gene mutations and cystic fibrosis | 2016 | Strong | Whole Exome Sequencing |
| MTHFR | Neural Tube Defects | Latin American | MTHFR polymorphisms and birth defects | 2015 | Weak | Population-Based Study |
| HLA-B27 | Ankylosing Spondylitis | Asian | Association between HLA-B27 and ankylosing spondylitis | 2014 | Strong | Genetic Association Study |
| VEGF | Age-related Macular Degeneration | European | VEGF polymorphisms in AMD patients | 2018 | Moderate | Cohort Study |
| SLC6A4 | Major Depressive Disorder | Multiple Ethnicities | Serotonin transporter gene and depression | 2014 | Weak | Candidate Gene Study |
| TYR | Albinism | African | TYR mutations associated with Oculocutaneous Albinism | 2019 | Strong | Mutation Analysis |
| KRAS | Colorectal Cancer | Asian | KRAS mutation and colorectal cancer prognosis | 2016 | Strong | Case-Control Study |
| MSH2 | Lynch Syndrome | Caucasian | MSH2 mutations and risk of colorectal cancer | 2020 | Strong | Familial Cancer Study |
| COMT | Schizophrenia | European | COMT polymorphisms and schizophrenia risk | 2002 | Weak | Genetic Association Study |
| ABCA1 | Cardiovascular Disease | Caucasian | ABCA1 gene variants in lipid metabolism | 2013 | Moderate | Population-Based Study |
| IL6 | Rheumatoid Arthritis | European | IL6 gene polymorphisms and RA | 2018 | Weak | Cohort Study |
| PTEN | Cowden Syndrome | Caucasian | Role of PTEN in hereditary cancers | 2018 | Strong | Genetic Testing Study |
| TPP1 | Batten Disease | Caucasian | TPP1 mutations in Batten disease | 2017 | Strong | Exome Sequencing |
| ATRX | Alpha Thalassemia | African | ATRX gene variants and alpha thalassemia | 2020 | Moderate | Genetic Screening |
| DRD2 | Addiction | European | DRD2 polymorphisms and substance abuse | 2016 | Weak | Case-Control Study |
| TMEM106B | Frontotemporal Dementia | Caucasian | TMEM106B and neurodegenerative disorders | 2012 | Moderate | Genetic Association Study |
| APOE | Cardiovascular Disease | Asian | APOE gene variants and cardiovascular risk | 2018 | Weak | Meta-Analysis |
| CDKN2A | Melanoma | Australian | CDKN2A mutations in familial melanoma | 2015 | Strong | Case-Control Study |
| GSTP1 | Prostate Cancer | European | GSTP1 polymorphisms and prostate cancer susceptibility | 2019 | Weak | Case-Control Study |
| ACE | Hypertension | European | ACE gene insertion/deletion polymorphism and hypertension | 2000 | Moderate | Cohort Study |
| UQCRC1 | Parkinson's Disease | European | Mitochondrial genetic risk factors for PD | 2020 | Weak | Genetic Screening |
| NTRK1 | Congenital Insensitivity | Caucasian | NTRK1 mutations in congenital insensitivity to pain | 2018 | Strong | Exome Sequencing |
| FANCA | Fanconi Anemia | Caucasian | FANCA mutations in Fanconi anemia | 2016 | Strong | Cohort Study |
| VHL | Von Hippel-Lindau Syndrome | Caucasian | VHL mutations and cancer predisposition | 2019 | Strong | Familial Cancer Study |
| HER2 | Breast Cancer | Caucasian | HER2 amplification and breast cancer | 2021 | Strong | Genetic Testing |
| PLG | Thrombophilia | European | PLG mutations associated with thrombophilia | 2020 | Weak | Genetic Testing |
| TNF | Inflammatory Bowel Disease | European | TNF gene polymorphisms and IBD susceptibility | 2017 | Moderate | Case-Control Study |
| GBA | Parkinson's Disease | Ashkenazi Jewish | GBA mutations linked to Parkinson's disease | 2016 | Strong | Genetic Association Study |
| NOTCH1 | Leukemia | Caucasian | NOTCH1 mutations in T-cell acute lymphoblastic leukemia | 2021 | Strong | Exome Sequencing |
| PTCH1 | Basal Cell Carcinoma | Caucasian | PTCH1 mutations in basal cell carcinoma | 2019 | Strong | Genetic Testing |
| SCN1A | Dravet Syndrome | Caucasian | SCN1A mutations and epilepsy disorders | 2017 | Strong | Exome Sequencing |
| RHO | Retinitis Pigmentosa | Caucasian | RHO mutations in inherited retinal dystrophies | 2020 | Strong | Genetic Analysis |
| LAMA2 | Congenital Muscular Dystrophy | Caucasian | LAMA2 mutations in muscular dystrophy | 2018 | Strong | Cohort Study |
| SHH | Holoprosencephaly | Caucasian | SHH pathway mutations in congenital malformations | 2016 | Moderate | Genetic Case Study |
| COL3A1 | Ehlers-Danlos Syndrome | Caucasian | COL3A1 mutations in vascular EDS | 2018 | Strong | Genetic Screening |
| TGFBR1 | Marfan Syndrome | Caucasian | TGFBR1 variants and Marfan syndrome | 2020 | Strong | Genetic Screening |
| SERTAD1 | Breast Cancer | Asian | Novel gene variants associated with breast cancer | 2019 | Weak | Family-Based Study |
| HNF1A | Maturity Onset Diabetes | European | HNF1A mutations in diabetes patients | 2017 | Moderate | Cohort Study |
| MUC5B | Idiopathic Pulmonary Fibrosis | Caucasian | MUC5B and pulmonary fibrosis susceptibility | 2020 | Moderate | Genetic Analysis |
| FH | Hereditary Fumarate Hydratase Deficiency | Caucasian | FH mutations and metabolic disorders | 2019 | Strong | Genetic Analysis |
| TCEAL1 | Multiple Sclerosis | European | TCEAL1 implications in autoimmunity | 2017 | Weak | Genetic Screening |
| DMD | Duchenne Muscular Dystrophy | Caucasian | DMD gene mutations in muscular dystrophy | 2020 | Strong | Genetic Testing |
| MAP2K1 | Melanoma | Caucasian | MAP2K1 mutations in skin cancer | 2019 | Strong | Exome Sequencing |
| KCNQ1 | Long QT Syndrome | Caucasian | KCNQ1 gene variants in congenital LQT | 2018 | Strong | Cohort Study |
| CHRNA4 | Epilepsy | European | CHRNA4 mutations and epilepsy syndromes | 2020 | Strong | Genetic Characterization |
| PTPN11 | Noonan Syndrome | Caucasian | PTPN11 and developmental disorders | 2018 | Strong | Gene Sequencing |
| MLH1 | Lynch Syndrome | Caucasian | MLH1 mutations linked to colorectal cancer | 2020 | Strong | Genetic Testing |
| MSH6 | Lynch Syndrome | Caucasian | MSH6 gene alterations in cancer risk | 2021 | Strong | Family-Based Study |
| SOS1 | Noonan Syndrome | Caucasian | SOS1 mutations and clinical features | 2019 | Moderate | Genetic Diagnosis |
| FGFR2 | Cleft Lip/Palate | Asian | FGFR2 polymorphisms in craniofacial anomalies | 2017 | Weak | Cohort Study |
| SLC22A4 | Rheumatoid Arthritis | Caucasian | SLC22A4 gene and autoimmune diseases | 2016 | Weak | Genetic Association Study |
| CACNA1A | Migraine | European | CACNA1A variants in familial hemiplegic migraine | 2019 | Moderate | Gene Mapping |
| PHOX2B | Congenital Central Hypoventilation Syndrome | Caucasian | PHOX2B mutations and respiratory disorders | 2018 | Strong | Cohort Study |
| BRCA1 | Ovarian Cancer | European | BRCA1 mutations and ovarian cancer risk | 2020 | Strong | GWAS |
| AR | Prostate Cancer | Caucasian | AR gene variants and prostate cancer risk | 2021 | Strong | Genetic Analysis |
| CYP2D6 | Drug Metabolism | Caucasian | CYP2D6 polymorphisms affect drug metabolism | 2019 | Weak | Population-Based Study |
| TP53 | Ovarian Cancer | European | TP53 mutations and ovarian cancer | 2020 | Strong | Exome Sequencing |
| NCF4 | Chronic Granulomatous Disease | Caucasian | NCF4 mutations in immune disorders | 2018 | Strong | Cohort Study |
| NRAS | Melanoma | Caucasian | NRAS mutations in melanoma | 2018 | Strong | Genetic Testing |
| ERBB2 | Breast Cancer | Asian | ERBB2 variants linked to breast cancer | 2021 | Strong | Genetic Screening |
| JAK2 | Polycythemia Vera | Caucasian | JAK2 V617F and blood disorders | 2005 | Strong | Genetic Testing |
| BARD1 | Ovarian Cancer | European | BARD1 mutations in familial ovarian cancer | 2019 | Strong | Genetic Analysis |
| ACHE | Alzheimer's Disease | European | ACHE gene polymorphisms and Alzheimer's disease | 2016 | Weak | Cognitive Study |
| RARA | Acute Promyelocytic Leukemia | Caucasian | RARA mutations in leukemia | 2017 | Strong | Genetic Analysis |
| COL1A1 | Osteogenesis Imperfecta | Caucasian | COL1A1 mutations linked to brittle bone disorder | 2018 | Strong | Cohort Study |
| ITGB3 | Thrombophilia | Caucasian | ITGB3 gene variants and thrombosis risk | 2020 | Weak | Genetic Study |
| SURF1 | Leigh Syndrome | Caucasian | SURF1 mutations associated with Leigh syndrome | 2017 | Strong | Exome Sequencing |
| KMT2D | Kabuki Syndrome | Caucasian | KMT2D gene mutations in development disorders | 2018 | Strong | Genetic Analysis |
| RPE65 | Leber Congenital Amaurosis | Caucasian | RPE65 mutations and retinal disorders | 2017 | Strong | Gene Therapy Study |
| TTR | Familial Amyloid Polyneuropathy | Caucasian | TTR gene mutations in hereditary amyloidosis | 2020 | Strong | Cohort Study |
| GCK | Maturity-Onset Diabetes of the Young | European | GCK mutations and MODY | 2019 | Strong | Gene Sequencing |
| MC4R | Obesity | Caucasian | MC4R mutations and obesity in humans | 2020 | Strong | Cohort Study |
| LMNA | Laminopathies | European | LMNA mutations in muscular dystrophy | 2018 | Strong | Exome Sequencing |
| SRC | Colorectal Cancer | Asian | SRC mutations in tumorigenesis | 2017 | Weak | Genetic Screening |
| PTPRD | Schizophrenia | Caucasian | PTPRD gene variants linked to schizophrenia | 2020 | Weak | Genetic Study |
| SLC26A4 | Pendred Syndrome | Caucasian | SLC26A4 mutations in deafness and thyroid dysfunction | 2018 | Strong | Exome Sequencing |
| SPTLC1 | Hereditary Sensory Neuropathy | Caucasian | SPTLC1 mutations associated with sensory neuropathy | 2019 | Strong | Gene Analysis |
| PRPF31 | Retinitis Pigmentosa | Caucasian | PRPF31 mutations linked to retinal disorders | 2020 | Strong | Genetic Analysis |
| PAX6 | Aniridia | Caucasian | PAX6 mutations in congenital eye disorders | 2017 | Strong | Cohort Study |
| IL10 | Inflammatory Bowel Disease | European | IL10 gene polymorphisms and IBD risk | 2018 | Weak | Population-Based Study |
| PSEN1 | Alzheimer's Disease | Caucasian | PSEN1 mutations in familial Alzheimer's disease | 2019 | Strong | Genetic Testing |
| ADRB2 | Asthma | European | ADRB2 polymorphisms and asthma susceptibility | 2016 | Weak | Cohort Study |
| FAS | Autoimmune Diseases | Caucasian | FAS gene variants and susceptibility to autoimmune disorders | 2018 | Weak | Genetic Analysis |
| CYP1A2 | Caffeine Metabolism | European | CYP1A2 and its role in caffeine metabolism | 2020 | Weak | Cohort Study |
| CDKAL1 | Type 2 Diabetes | Middle Eastern | CDKAL1 gene variants associated with diabetes | 2013 | Moderate | Population-Based Study |
| EDAR | Ocular Anhidrosis | Asian | EDAR mutations linked to ectodermal dysplasia | 2019 | Strong | Gene Mapping |
| PTCH2 | Basal Cell Carcinoma | Caucasian | PTCH2 mutations and skin cancer risk | 2019 | Moderate | Cohort Study |
| GAPDH | Aging | European | GAPDH gene variants and aging | 2020 | Weak | Population-Based Study |
| WT1 | Wilms Tumor | Caucasian | WT1 mutations associated with childhood kidney cancer | 2016 | Strong | Genetic Study |
| ABCB1 | Drug Resistance | Caucasian | ABCB1 polymorphisms affecting drug response | 2019 | Moderate | Meta-Analysis |
| BNIP3 | Cancer Metabolism | Caucasian | BNIP3 gene and its role in tumor biology | 2020 | Weak | Cohort Study |
| FBN1 | Marfan Syndrome | Caucasian | FBN1 mutations related to Marfan syndrome | 2018 | Strong | Genetic Testing |
| RAG1 | Severe Combined Immunodeficiency | Caucasian | RAG1 mutations in immunodeficiency disorders | 2017 | Strong | Gene Sequencing |
| SEMA3E | Osteosarcoma | Caucasian | SEMA3E gene alterations in cancer progression | 2019 | Weak | Cohort Study |
| ALK | Non-Small Cell Lung Cancer | Asian | ALK rearrangements in lung cancer | 2018 | Strong | Genetic Analysis |
| DAXX | Thyroid Cancer | European | DAXX mutations in well-differentiated thyroid carcinoma | 2019 | Moderate | Genetic Investigation |
| CREBBP | Cohen Syndrome | Caucasian | CREBBP mutations involved in Cohen syndrome | 2020 | Strong | Genetic Testing |
| CHD7 | CHARGE Syndrome | Caucasian | CHD7 mutations associated with CHARGE syndrome | 2017 | Strong | Exome Sequencing |
| SMN1 | Spinal Muscular Atrophy | Caucasian | SMN1 gene deletions in SMA | 2016 | Strong | Genetic Screening |
| BCL2 | Lymphoma | Caucasian | BCL2 gene and its role in lymphoma | 2019 | Moderate | Case-Control Study |
| FUS | Amyotrophic Lateral Sclerosis | Caucasian | FUS mutations and ALS | 2020 | Strong | Genetic Analysis |
| RPSA | Acute Myeloid Leukemia | Caucasian | RPSA mutations implicated in AML | 2019 | Weak | Genetic Screening |
| SRY | Sex Development Disorders | Caucasian | SRY genes and sex development disruptions | 2018 | Strong | Genetic Study |
| JUN | Osteosarcoma | Caucasian | JUN gene alterations in cancer | 2019 | Weak | Genetic Analysis |
| FBN1 | Aneurysms | Caucasian | FBN1 gene mutations in arterial diseases | 2020 | Strong | Cohort Study |
| RUNX1 | Myeloid Malignancies | Caucasian | RUNX1 mutations in blood disorders | 2019 | Strong | Exome Sequencing |
| LIPC | Cardiovascular Disease | European | LIPC mutations linked to cardiovascular risk | 2016 | Moderate | Genetic Study |
| HNF4A | Maturity Onset Diabetes of the Young | Caucasian | HNF4A gene mutations in MODY | 2018 | Strong | Cohort Study |
| FGF23 | Phosphate Wasting Disorders | Caucasian | FGF23 mutations linked to renal phosphate wasting | 2020 | Moderate | Genetic Screening |
| TP53 | Various Cancers | Caucasian | TP53 mutations and tumorigenesis | 2020 | Strong | Genetic Testing |
| APC | Colorectal Cancer | Caucasian | APC mutations and familial adenomatous polyposis | 2019 | Strong | Genetic Study |
| HTT | Huntington's Disease | Caucasian | HTT gene CAG repeat expansions in HD | 2018 | Strong | Genetic Testing |
| MTHFR | Cardiovascular Disease | European | MTHFR C677T polymorphism and heart disease | 2017 | Weak | Meta-Analysis |
| SHANK3 | Pervasive Developmental Disorders | Caucasian | SHANK3 mutations and autism spectrum disorder | 2020 | Strong | Exome Sequencing |
| SCN9A | Erythromelalgia | Caucasian | SCN9A mutations in pain disorders | 2019 | Strong | Genetic Characterization |
| HNF1B | Renal Cysts | Caucasian | HNF1B mutations associated with renal problems | 2020 | Strong | Genetic Study |
| IDS | Hunter Syndrome | Caucasian | IDS gene mutations involved in lysosomal storage disorders | 2018 | Strong | Cohort Study |
| PMEL | Melanoma | Caucasian | PMEL mutations and melanoma susceptibility | 2019 | Weak | Genetic Investigation |
| RPL5 | Diamond Blackfan Anemia | Caucasian | RPL5 mutations linked to anemia | 2017 | Strong | Cohort Study |
| SMAD4 | Juvenile Polyposis Syndrome | Caucasian | SMAD4 mutations and polyposis syndrome | 2018 | Strong | Genetic Analysis |
| GRIN2A | Epileptic Encephalopathy | Caucasian | GRIN2A gene variants linked to epilepsy | 2019 | Strong | Case-Control Study |
| DLGAP2 | Attention Deficit Hyperactivity Disorder | Caucasian | DLGAP2 variants and ADHD | 2020 | Moderate | Genetic Study |
| MCM6 | Lactose Intolerance | European | MCM6 polymorphisms and lactase persistence | 2018 | Strong | Genetic Analysis |
| DLX5 | Congenital Deafness | Asian | DLX5 gene mutations linked to deafness | 2019 | Strong | Genetic Screening |
| PTPN22 | Rheumatoid Arthritis | Caucasian | PTPN22 variants associated with autoimmune diseases | 2018 | Weak | Genetic Study |
| FOXP2 | Language Development Disorders | Caucasian | FOXP2 mutations linked to speech disorders | 2020 | Strong | Genetic Analysis |
| IL23R | Psoriasis | Caucasian | IL23R polymorphisms and psoriasis susceptibility | 2018 | Moderate | Genetic Investigation |
| SNCB | Congenital Myopathy | Caucasian | SNCB mutations associated with muscle disorders | 2019 | Strong | Cohort Study |
| LYQ | Lung Cancer | Asian | LYQ polymorphisms linked to lung cancer | 2020 | Weak | Genetic Study |
| HOXD13 | Hand-foot-genital Syndrome | Caucasian | HOXD13 mutations in congenital malformations | 2017 | Strong | Genetic Screening |
| TBX20 | Cardiomyopathy | European | TBX20 mutations in myocardial disease | 2018 | Strong | Cohort Study |
| ZNF423 | Breast Cancer | Caucasian | ZNF423 gene and hereditary breast cancer risk | 2020 | Moderate | Exome Sequencing |
| VHL | Clear Cell Renal Carcinoma | Caucasian | VHL gene alterations and renal cancer | 2019 | Strong | Genetic Testing |
| MT-TL1 | Mitochondrial Myopathy | Caucasian | MT-TL1 mutations associated with mitochondrial disorders | 2018 | Strong | Exome Sequencing |
| CAMK2A | Cognitive Disorders | Caucasian | CAMK2A mutations linked to learning disabilities | 2019 | Weak | Genetic Study |
| SPTA1 | Spherocytosis | Caucasian | SPTA1 mutations in hereditary spherocytosis | 2020 | Strong | Cohort Study |
| VCP | Inclusion Body Myopathy | Caucasian | VCP gene mutations in neuromuscular conditions | 2019 | Strong | Exome Sequencing |
| DOCK8 | Hyper-IgE Syndrome | Caucasian | DOCK8 mutations and immunodeficiency | 2018 | Strong | Genetic Testing |
| NF1 | Neurofibromatosis | Caucasian | NF1 mutations linked to neurofibromatosis type 1 | 2019 | Strong | Genetic Screening |
| RHEB | Tuberous Sclerosis Complex | Caucasian | RHEB mutations in tumor formation | 2020 | Moderate | Cohort Study |
| PTPN1 | Type 1 Diabetes | Caucasian | PTPN1 variants and susceptibility to diabetes | 2019 | Weak | Genetic Investigation |
| NEB | Nemaline Myopathy | Caucasian | NEB gene and its relation to muscle disorders | 2020 | Strong | Exome Sequencing |
| TREM2 | Alzheimer's Disease | Caucasian | TREM2 mutations in late-onset Alzheimer's | 2018 | Moderate | Genetic Study |
| SLC20A2 | Idiopathic Hypoparathyroidism | Caucasian | SLC20A2 mutations in calcium metabolism disorders | 2019 | Strong | Cohort Study |
| DPH5 | Neonatal Meningoencephalitis | Caucasian | DPH5 mutations and congenital disorders | 2018 | Strong | Genetic Screening |
| HOXA13 | Hand and Foot Malformations | Caucasian | HOXA13 gene mutations and limb malformations | 2020 | Moderate | Exome Sequencing |
| KCNQ1 | Cardiac Arrhythmias | European | KCNQ1 mutations affecting cardiac rhythm | 2019 | Strong | Cohort Study |
| CEBPA | Acute Myeloid Leukemia | Caucasian | CEBPA mutations in AML patient populations | 2020 | Strong | Genetic Testing |
| XPC | Nucleotide Excision Repair Deficiency | Caucasian | XPC gene mutations and cancer risk | 2019 | Moderate | Genetic Screening |
| RAD51D | Ovarian Cancer | Caucasian | RAD51D mutations in hereditary cancer syndromes | 2020 | Strong | Exome Sequencing |
| MSH2 | Endometrial Cancer | Caucasian | MSH2 variants associated with endometrial tumors | 2018 | Strong | Cohort Study |
| MYH9 | Giant Platelet Disorder | Caucasian | MYH9 mutations and bleeding disorders | 2019 | Strong | Genetic Analysis |
| MIR196A2 | Breast Cancer | Caucasian | MicroRNA polymorphisms and cancer risk | 2021 | Weak | Cohort Study |
| SH2B3 | Type 1 Diabetes | Caucasian | SH2B3 variants in autoimmune diseases | 2019 | Weak | Genetic Study |
| OSR1 | Congenital Kidney Disease | Caucasian | OSR1 mutations affecting renal function | 2018 | Strong | Cohort Study |
| ZFHX3 | Cardiomyopathy | Caucasian | ZFHX3 mutations linked to heart disease | 2019 | Moderate | Cohort Study |
| CDH1 | Hereditary Diffuse Gastric Cancer | Caucasian | CDH1 mutations and cancer risk | 2019 | Strong | Genetic Testing |
| RPL11 | Diamond Blackfan Anemia | Caucasian | RPL11 mutations associated with blood disorders | 2020 | Strong | Genetic Study |
| GUCY2D | Leber Congenital Amaurosis | Caucasian | GUCY2D mutations and blindness | 2018 | Strong | Exome Sequencing |
| GHR | Short Stature | Caucasian | GHR mutations associated with short stature | 2019 | Weak | Cohort Study |
| POLD1 | Colorectal Cancer | Caucasian | POLD1 mutations linked to familial CRC | 2020 | Strong | Exome Sequencing |
| BMP4 | Cleft Palate | Caucasian | BMP4 gene variants and facial clefts | 2019 | Weak | Genetic Investigation |
| AGRN | Congenital Myasthenic Syndromes | Caucasian | AGRN mutations in neuromuscular disorders | 2020 | Strong | Cohort Study |
| RANBP2 | Cohesive Tumors | Caucasian | RANBP2 mutations and cancer progression | 2020 | Weak | Genetic Screening |
| AFG3L2 | Spinocerebellar Ataxia | Caucasian | AFG3L2 mutations in neurodegenerative disorders | 2018 | Strong | Exome Sequencing |
| HESX1 | Congenital Hypopituitarism | Caucasian | HESX1 mutations and pituitary disorders | 2020 | Strong | Genetic Analysis |
| ZBTB7A | Acute Myeloid Leukemia | Caucasian | ZBTB7A variants linked to blood cancers | 2019 | Moderate | Genetic Screening |
| IDH1 | Glioma | Caucasian | IDH1 mutations in brain tumors | 2019 | Strong | Exome Sequencing |
| FREM1 | Congenital Anomalies | Caucasian | FREM1 variants and developmental disorders | 2020 | Strong | Genetic Study |
| SMAD2 | Renal Cell Carcinoma | Caucasian | SMAD2 gene alterations related to kidney cancer | 2019 | Weak | Cohort Study |
| USP7 | Various Cancers | Caucasian | USP7 mutations and clinical implications in cancer | 2020 | Moderate | Genetic Investigation |
| ETV6 | Childhood Leukemia | Caucasian | ETV6 mutations and hematological cancers | 2019 | Strong | Genetic Analysis |
| CA5B | Congenital Metabolic Disorders | Caucasian | CA5B mutations leading to metabolic disturbances | 2020 | Strong | Cohort Study |
| OTX2 | Blindness | Caucasian | OTX2 mutations in severe vision impairment | 2018 | Strong | Genetic Analysis |
| AGPHD1 | Hypomyelination Disorders | Caucasian | AGPHD1 mutations associated with neurological disorders | 2020 | Strong | Cohort Study |
| NF2 | Neurofibromatosis | Caucasian | NF2 gene and schwannomas | 2019 | Strong | Genetic Screening |
| TMEM174 | Autoimmune Diseases | Caucasian | TMEM174 variants and immune system disorders | 2019 | Moderate | Case-Control Study |
| RB1 | Retinoblastoma | Caucasian | RB1 mutations in familial retinoblastoma | 2021 | Strong | Genetic Testing |
| CLN3 | Batten Disease | Caucasian | CLN3 mutations associated with neurodegeneration | 2018 | Strong | Cohort Study |
| SPTBN2 | Neurodevelopmental Disorders | Caucasian | SPTBN2 mutations linked to cognitive disability | 2020 | Weak | Genetic Analysis |
| NR6A1 | AARR Androgen Insensitivity Syndrome | Caucasian | NR6A1 mutations and sexual development disorders | 2019 | Strong | Exome Sequencing |
| PALB2 | Breast Cancer | Caucasian | PALB2 mutations in familial breast cancer | 2020 | Strong | Cohort Study |
| TAF1 | X-Linked Dystonia-Parkinsonism | Filipino | TAF1 mutations and movement disorders | 2020 | Strong | Genetic Testing |
| PLIN1 | Obesity | Caucasian | PLIN1 mutations linked to obesity and metabolic disorders | 2019 | Strong | Cohort Study |
| ATP2A2 | Darier's Disease | Caucasian | ATP2A2 mutations and skin disorders | 2020 | Strong | Genetic Investigation |
| MAP3K1 | Breast Cancer | Caucasian | MAP3K1 gene and breast tumor susceptibility | 2020 | Moderate | Cohort Study |
| ICAM1 | Cardiovascular Disease | Caucasian | ICAM1 polymorphisms and heart disease risk | 2018 | Weak | Genetic Study |
| ZNF423 | Lung Cancer | Caucasian | ZNF423 gene and tumor susceptibility | 2019 | Moderate | Exome Sequencing |
| PTPRC | Autoimmune Thyroid Disease | Caucasian | PTPRC variants in thyroid conditions | 2020 | Weak | Cohort Study |
| MSRA | Aging | Caucasian | MSRA polymorphisms and longevity | 2019 | Weak | Genetic Study |
| CH7 | Lung Cancer | Caucasian | CH7 gene mutations associated with lung cancer | 2020 | Weak | Genetic Investigation |
| SLC1A1 | Epilepsy | European | SLC1A1 mutations associated with epilepsy disorders | 2020 | Strong | Genetic Testing |
| SOCS2 | Growth Disorders | Caucasian | SOCS2 gene and endocrine dysfunctions | 2018 | Strong | Cohort Study |
| CA5A | Carboxylic Acid Reactivity | Caucasian | CA5A polymorphisms related to metabolic reactions | 2020 | Weak | Genetic Analysis |
| ZNF384 | Acute Lymphoblastic Leukemia | Caucasian | ZNF384 mutations in leukemia | 2019 | Strong | Genetic Investigation |
| RET | Multiple Endocrine Neoplasia | Caucasian | RET mutations and MEN syndromes | 2020 | Strong | Genetic Analysis |
| RBM8A | Fanconi Anemia Type A | Caucasian | RBM8A mutations in blood disorders | 2019 | Strong | Exome Sequencing |
| GREM1 | Colorectal Cancer | Caucasian | GREM1 gene alterations linked to cancer | 2020 | Strong | Cohort Study |
| TTC7A | Congenital Disorders | Caucasian | TTC7A mutations linked to immune dysregulation | 2019 | Strong | Genetic Analysis |
| CYBB | Chronic Granulomatous Disease | Caucasian | CYBB mutations associated with immune disorders | 2020 | Strong | Genetic Testing |
| TBG | Hypothyroidism | Caucasian | TBG mutations linked to thyroid dysfunction | 2020 | Moderate | Genetic Investigation |
| P2RY8 | B Cell Disorders | Caucasian | P2RY8 mutations associated with blood disorders | 2019 | Strong | Genetic Screening |
| FBXO31 | Breast Cancer | Caucasian | FBXO31 mutations associated with breast cancer risk | 2021 | Moderate | Exome Sequencing |
| CPS1 | Urea Cycle Disorders | Caucasian | CPS1 mutations linked to metabolic diseases | 2019 | Strong | Case-Control Study |
| RAG2 | SCID | Caucasian | RAG2 mutations and immune deficiency | 2020 | Strong | Cohort Study |
| CYP2C9 | Warfarin Sensitivity | Caucasian | CYP2C9 polymorphisms affect warfarin metabolism | 2020 | Moderate | Genetic Screening |
| COL4A5 | Alport Syndrome | Caucasian | COL4A5 mutations associated with kidney disease | 2018 | Strong | Genetic Testing |
| DSG2 | Cardiomyopathy | Caucasian | DSG2 mutations and heart failure risk | 2019 | Strong | Cohort Study |
| TRPM6 | Hypomagnesemia | Caucasian | TRPM6 mutations leading to magnesium deficiency | 2018 | Moderate | Genetic Investigation |
| PLAU | Thromboembolic Disorders | Caucasian | PLAU mutations and thrombotic risk | 2020 | Weak | Cohort Study |
| RCC1 | Lymphoblastic Leukemia | Caucasian | RCC1 mutations and leukemia risk | 2020 | Strong | Genetic Analysis |
| RAB27A | Griscelli Syndrome | Caucasian | RAB27A mutations affecting immune responses | 2020 | Strong | Genetic Screening |
| UQCRH | Mitochondrial Disorders | Caucasian | UQCRH mutations linked to mitochondrial diseases | 2021 | Weak | Exome Sequencing |
| CCL5 | Cancer Progression | Caucasian | CCL5 polymorphisms linked to cancer aggressiveness | 2020 | Weak | Genetic Investigation |
| SARO | Neuromuscular Disorders | Caucasian | SARO gene mutations related to muscle disease | 2020 | Strong | Exome Sequencing |
| ASS1 | Citrullinemia | Caucasian | ASS1 mutations linked to metabolic disorders | 2017 | Strong | Cohort Study |
| RHEB | Cardiovascular Risk | Caucasian | RHEB mutations in heart diseases | 2019 | Weak | Gene Testing |
| USH2A | Usher Syndrome | Caucasian | USH2A mutations leading to hearing loss | 2018 | Strong | Exome Sequencing |
| ALK | Lung Cancer Resistance | Caucasian | ALK mutations in resistance mechanisms of cancer | 2020 | Strong | Genetic Testing |
| RXRA | Hormonal Disorders | Caucasian | RXRA mutations and metabolic regulation disturbances | 2020 | Weak | Genetic Investigation |
| UBR5 | Hypertrophic Cardiomyopathy | Caucasian | UBR5 mutations linked with cardiac function | 2019 | Strong | Cohort Study |
| HECW2 | Neonatal Birth Defects | Caucasian | HECW2 mutations causing congenital malformations | 2020 | Strong | Exome Sequencing |
| HRAS | Various Cancers | Caucasian | HRAS mutations linked to tumorigenesis | 2020 | Strong | Genetic Testing |
| RPSA | Schizophrenia | Caucasian | RPSA gene variants impacting neurodevelopment | 2020 | Weak | Genetic Analysis |
| YY1 | Biorhythm Disorders | Caucasian | YY1 mutations linked to sleep disturbances | 2020 | Weak | Genetic Screening |
| ABCA2 | Neurological Disorders | Caucasian | ABCA2 mutations related to neurological function | 2020 | Strong | Exome Sequencing |
| RHOB | Multiple Sclerosis | Caucasian | RHOB variants linked to autoimmune diseases | 2020 | Moderate | Genetic Investigation |
| SLC38A1 | Neurodevelopmental Disorders | Caucasian | SLC38A1 mutations causing cognitive disabilities | 2020 | Strong | Cohort Study |
| CYP3A5 | Drug Metabolism | Caucasian | CYP3A5 variants in personalized medicine | 2020 | Weak | Meta-Analysis |
| PPP1R12A | Cardiomyopathy | Caucasian | PPP1R12A mutations affecting heart conditions | 2020 | Moderate | Genetic Study |
| GRK5 | Heart Failure | Caucasian | GRK5 variants linked with cardiac function | 2020 | Weak | Genetic Investigation |
| PTPRD | Brain Tumors | Caucasian | PTPRD mutations and glioma | 2020 | Strong | Cohort Study |
| MAPK8IP3 | Hematopoietic Disorders | Caucasian | MAPK8IP3 mutations leading to blood problems | 2020 | Weak | Genetic Testing |
| CTCF | Neoplastic Diseases | Caucasian | CTCF gene alterations in tumorigenesis | 2019 | Strong | Exome Sequencing |
| PGRN | Frontotemporal Dementia | Caucasian | PGRN mutations linked to neurodegenerative disorders | 2020 | Strong | Cohort Study |
| ARMC5 | Adrenal Insufficiency | Caucasian | ARMC5 variants causing adrenal disorders | 2020 | Strong | Genetic Screening |
| RBM15 | Acute Myeloid Leukemia | Caucasian | RBM15 mutations in blood cancers | 2020 | Strong | Genetic Analysis |
| MYD88 | Lymphoma | Caucasian | MYD88 mutations linked to cancer of lymphatic tissues | 2020 | Weak | Cohort Study |
| CREBBP | Neurodevelopmental Disorders | Caucasian | CREBBP mutations associated with cognitive issues | 2020 | Strong | Exome Sequencing |
| LDB3 | Cardiomyopathy | Caucasian | LDB3 mutations leading to heart diseases | 2020 | Strong | Cohort Study |
| APLNR | Obesity | Caucasian | APLNR gene variants linked with metabolic disorders | 2020 | Weak | Genetic Investigation |
| RHEB | Neurodegeneration | Caucasian | RHEB mutations associated with brain diseases | 2020 | Weak | Genetic Study |
| RPSA | Diabetes Type 1 | Caucasian | RPSA gene variants associated with autoimmune diseases | 2020 | Weak | Cohort Study |
| CLDN16 | Magnesium Wasting | Caucasian | CLDN16 mutations cause renal diseases | 2020 | Strong | Genetic Analysis |
| FBLIM1 | Skeletal Dysplasia | Caucasian | FBLIM1 mutations linked to bone growth disorders | 2020 | Weak | Case-Control Study |
| LST1 | Chronic Inflammatory Disease | Caucasian | LST1 variants linked to chronic diseases | 2020 | Weak | Population-Based Study |
| FMR1 | Fragile X Syndrome | Caucasian | FMR1 mutations associated with development disorders | 2021 | Strong | Genetic Testing |
| RBP4 | Diabetes Risk | Caucasian | RBP4 gene variants affect glucose metabolism | 2020 | Moderate | Cohort Study |
| CMTM7 | Bacterial Infections | Caucasian | CMTM7 mutations linked to susceptibility | 2020 | Weak | Genetic Investigation |
| ACE | Chronic Kidney Disease | Caucasian | ACE gene polymorphisms influence kidney disease | 2020 | Weak | Case-Control Study |
| FBXL4 | Mitochondrial Disorders | Caucasian | FBXL4 mutations leading to energy metabolism issues | 2020 | Strong | Cohort Study |
| COL4A6 | Alport Syndrome | Caucasian | COL4A6 mutations linked to kidney disease | 2020 | Strong | Exome Sequencing |
| GLT8D1 | Alzheimer's Disease | Caucasian | GLT8D1 mutations linked to Alzheimer's risk | 2020 | Strong | Cohort Study |
| DGCR8 | Microcephaly | Caucasian | DGCR8 mutations leading to brain size disorders | 2020 | Weak | Genetic Investigation |
| TSEN54 | Biosynthesis Disorders | Caucasian | TSEN54 mutations linked to tRNA processing disorders | 2020 | Strong | Cohort Study |
| COL9A1 | Familiar Osteochondromatosis | Caucasian | COL9A1 variants associated with skeletal disorders | 2020 | Weak | Genetic Analysis |
| NAT2 | Drug Sensitivity | Caucasian | NAT2 polymorphisms affect drug response | 2020 | Weak | Case-Control Study |
| FGB | Thrombosis Risk | Caucasian | FGB mutations associated with blood clots | 2020 | Strong | Cohort Study |
| RAB8A | Neurodevelopmental Disorders | Caucasian | RAB8A mutations linked to neurological conditions | 2020 | Weak | Genetic Testing |
| SDHAF2 | Paraganglioma Syndromes | Caucasian | SDHAF2 mutations associated with carcinogenesis | 2020 | Strong | Cohort Study |
| BRIP1 | Ovarian Cancer | Caucasian | BRIP1 mutations leading to cancer predisposition | 2020 | Strong | Genetic Screening |
| AIR | Liver Function Disorders | Caucasian | AIR mutations linked to metabolic functions | 2020 | Weak | Genetic Investigation |
| TBX20 | Heart Disease | Caucasian | TBX20 mutations affect cardiac tissue | 2019 | Strong | Genetic Study |
| ADAMTS13 | Thrombotic Thrombocytopenic Purpura | Caucasian | ADAMTS13 mutations and blood thrombotic disorders | 2020 | Strong | Cohort Study |
| TNNT2 | Hypertrophic Cardiomyopathy | Caucasian | TNNT2 mutations leading to heart issues | 2020 | Strong | Genetic Screening |
| ARID1A | Ovarian Cancer | Caucasian | ARID1A mutations linked with ovarian cancer | 2020 | Strong | Exome Sequencing |
| MYF6 | Skeletal Disorders | Caucasian | MYF6 mutations associated with bone growth | 2020 | Weak | Genetic Investigation |
| GLYAT | Toxicological Disorders | Caucasian | GLYAT mutations linked to detoxification disorders | 2020 | Strong | Cohort Study |
| IL22RA1 | Inflammatory Bowel Disease | Caucasian | IL22RA1 variants linked to bowel disorders | 2020 | Weak | Genetic Analysis |
| NPTN | Neurodevelopmental Disorders | Caucasian | NPTN mutations associated with cognitive issues | 2020 | Strong | Exome Sequencing |
| GRK5 | Cardiac Function | Caucasian | GRK5 mutations leading to heart complications | 2020 | Weak | Cohort Study |
| PNPT1 | Mitochondrial Disorders | Caucasian | PNPT1 mutations linked to mitochondrial dysfunction | 2020 | Strong | Cohort Study |
| ASXL1 | Myelodysplastic Syndromes | Caucasian | ASXL1 mutations associated with blood cancers | 2020 | Strong | Genetic Study |
| PMS2 | Lynch Syndrome | Caucasian | PMS2 mutations and cancer risk | 2020 | Strong | Exome Sequencing |
| THOC6 | Neuronal Disorders | Caucasian | THOC6 mutations linked to cognitive disabilities | 2020 | Strong | Cohort Study |
| CSF1R | Neoplasia Disorders | Caucasian | CSF1R mutations leading to tumors | 2020 | Strong | Cohort Study |
| SDHAF1 | Paraganglioma Syndromes | Caucasian | SDHAF1 mutations affecting tumor formation | 2020 | Strong | Exome Sequencing |
| ATP7B | Wilson's Disease | Caucasian | ATP7B mutations linked to copper metabolism disorders | 2020 | Strong | Genetic Testing |
| PTGFR | Obesity | Caucasian | PTGFR gene linked to metabolic conditions | 2020 | Weak | Cohort Study |
| BARD1 | Breast Cancer | Caucasian | BARD1 mutations associated with breast cancer | 2020 | Strong | Cohort Study |
| BAK1 | Cancer Progression | Caucasian | BAK1 variant mutations linked with cancer | 2020 | Moderate | Genetic Screening |
| HMGCR | Hyperlipidemia | Caucasian | HMGCR mutations linked to dyslipidemia | 2020 | Weak | Genetic Investigation |
| RGPD5 | Cancer Resistance | Caucasian | RGPD5 mutations in cancer survival | 2020 | Weak | Cohort Study |
| FAM111A | Aging Disorders | Caucasian | FAM111A mutations linked to aging | 2020 | Strong | Exome Sequencing |
| SLC16A1 | Fatty Acid Metabolism | Caucasian | SLC16A1 mutations linked to metabolic disorders | 2020 | Weak | Cohort Study |
| SPTA1 | Anemia Disorders | Caucasian | SPTA1 mutations linked to hereditary anemias | 2020 | Strong | Cohort Study |
| RANBP2 | Neurodevelopmental Disorders | Caucasian | RANBP2 mutations affecting brain growth | 2020 | Weak | Cohort Study |
| SHOC2 | Cognitive Functional Disorders | Caucasian | SHOC2 mutations linked to intellectual disability | 2020 | Strong | Exome Sequencing |
| MAP3K3 | Cardiovascular Disorders | Caucasian | MAP3K3 gene alterations linked to heart disease | 2020 | Weak | Cohort Study |
| CDC73 | Hyperparathyroidism | Caucasian | CDC73 mutations and parathyroid disorders | 2020 | Strong | Exome Sequencing |
| ADAP1 | Immune System Disorders | Caucasian | ADAP1 mutations and immune dysfunction | 2020 | Moderate | Genetic Study |
| TFG | Lymphoma | Caucasian | TFG mutations and cancer progression | 2020 | Weak | Cohort Study |
| MGAT5 | Autoimmune Diseases | Caucasian | MGAT5 variants linked to autoimmune conditions | 2020 | Weak | Genetic Investigation |
| CPT1A | Fatty Acid Oxidation Disorders | Caucasian | CPT1A mutations linked to metabolic syndromes | 2020 | Strong | Exome Sequencing |
| FICO | Cardiovascular Disease | Caucasian | FICO mutations associated with heart disease | 2020 | Weak | Population-Based Study |
| ACTA1 | Congenital Myopathy | Caucasian | ACTA1 mutations and muscle disorders | 2020 | Strong | Exome Sequencing |
| GLA | Fabry Disease | Caucasian | GLA mutations leading to lysosomal storage disorders | 2020 | Strong | Cohort Study |
| SMARCA4 | Small Cell Carcinoma | Caucasian | SMARCA4 variations linked to cancer progress | 2020 | Strong | Exome Sequencing |
| TP53 | Lung Cancer | Caucasian | TP53 mutations in lung cancer prognosis | 2020 | Strong | Cohort Study |
| JAK2 | Polycythemia Vera | Caucasian | JAK2 mutations in blood disorders | 2020 | Strong | Exome Sequencing |
| PIK3CA | Breast Cancer | Caucasian | PIK3CA mutations and tumorigenesis | 2020 | Strong | Cohort Study |
| SLC35B1 | Congenital Disorder | Caucasian | SLC35B1 mutations linked to metabolic disorders | 2020 | Weak | Genetic Investigation |
| CTNNB1 | Endometrial Cancer | Caucasian | CTNNB1 mutations in endometrial tumors | 2020 | Strong | Exome Sequencing |
| LRP5 | Osteoporosis | Caucasian | LRP5 variants associated with bone density | 2020 | Weak | Cohort Study |
| PIK3R1 | Various Cancers | Caucasian | PIK3R1 mutations linked to cancer risk | 2020 | Strong | Cohort Study |
| DNAH5 | Immotile Cilia Syndrome | Caucasian | DNAH5 mutations in respiratory disorders | 2020 | Strong | Exome Sequencing |
| ULK4 | Lung Cancer | Caucasian | ULK4 mutations associated with cancers | 2020 | Weak | Cohort Study |
| CHEK2 | Breast Cancer | Caucasian | CHEK2 mutations linked to breast cancer | 2020 | Strong | Cohort Study |
| FAF1 | Neuromuscular Disorders | Caucasian | FAF1 mutations leading to muscle issues | 2020 | Strong | Cohort Study |
| DYP | Osteosarcoma | Caucasian | DYP mutations associated with bone tumors | 2020 | Weak | Genetic Investigation |
| SETD2 | Kidney Cancer | Caucasian | SETD2 mutations linked to renal neoplasms | 2020 | Strong | Cohort Study |
| AGL | Glycogen Storage Disorders | Caucasian | AGL mutations associated with metabolism disorders | 2020 | Strong | Exome Sequencing |
| NFATC4 | Autoimmune Conditions | Caucasian | NFATC4 variations linked to immune disorders | 2020 | Weak | Genetic Study |
| ACAN | Intervertebral Disc Disorders | Caucasian | ACAN mutations linked to disc degeneration | 2020 | Weak | Cohort Study |
| BRD4 | Multiple Myeloma | Caucasian | BRD4 mutations linked to blood cancers | 2020 | Strong | Cohort Study |
| TEAD1 | Facial Dysmorphism | Caucasian | TEAD1 mutations causing developmental anomalies | 2020 | Weak | Genetic Investigation |
| BRCA2 | Ovarian Cancer | Caucasian | BRCA2 mutations associated with ovarian cancer risk | 2020 | Strong | Exome Sequencing |
| PPP1CA | Neurodegenerative Disorders | Caucasian | PPP1CA mutations related to cognitive decline | 2020 | Weak | Cohort Study |
| HLA-DQA1 | Autoimmune Disorders | Caucasian | HLA-DQA1 variants associated with diseases | 2020 | Weak | Genetic Testing |
| HSF1 | Neuromuscular Disorders | Caucasian | HSF1 mutations linked to muscle disorders | 2020 | Strong | Cohort Study |
| CASP10 | Autoimmune Diseases | Caucasian | CASP10 variants linked to immune syndromes | 2020 | Weak | Exome Sequencing |
| IRF8 | Immune Disorders | Caucasian | IRF8 mutations linked to susceptibility | 2020 | Weak | Genetic Testing |
| GLC | Obesity Risk | Caucasian | GLC variants affecting metabolic rates | 2020 | Weak | Case-Control Study |
| DMBT1 | Cysts | Caucasian | DMBT1 mutations linked to developmental anomalies | 2020 | Moderate | Genetic Investigation |
| FBXO10 | Cardiomyopathy | Caucasian | FBXO10 mutations associated with heart failure | 2020 | Strong | Exome Sequencing |
| SGK1 | Obesity | Caucasian | SGK1 variants linked to body weight | 2020 | Moderate | Cohort Study |
| RGS2 | Hypertension | Caucasian | RGS2 variants linked to blood pressure | 2020 | Weak | Genetic Investigation |
| RAPGEF1 | Cancer Progression | Caucasian | RAPGEF1 mutations associated with cancer | 2020 | Weak | Cohort Study |
| SPP1 | Bone Density Disorders | Caucasian | SPP1 mutations linked with osteoporosis | 2020 | Strong | Cohort Study |
| HNF4A | Diabetes Type 2 | Caucasian | HNF4A mutations affecting glucose levels | 2020 | Weak | Genetic Testing |
| RUNX1 | Blood Malignancies | Caucasian | RUNX1 mutations linked to leukemia | 2020 | Strong | Cohort Study |
| TET2 | Asthma | Caucasian | TET2 mutations associated with respiratory issues | 2020 | Weak | Genetic Analysis |
| RYR1 | Ryanodine Receptor Disorders | Caucasian | RYR1 mutations leading to muscle problems | 2020 | Strong | Cohort Study |
| RPE65 | Leber Congenital Amaurosis | Caucasian | RPE65 mutations causing retinal issues | 2020 | Strong | Exome Sequencing |
| ERBB2 | Breast Cancer | Caucasian | ERBB2 mutations linked to breast cancer | 2020 | Strong | Cohort Study |
| EXOSC3 | Neuropathy Disorders | Caucasian | EXOSC3 mutations linked with neural deficits | 2020 | Strong | Exome Sequencing |
| CYP27A1 | Cholesterol Metabolism Disorders | Caucasian | CYP27A1 mutations affecting metabolism | 2020 | Strong | Cohort Study |
| LAMB1 | Laminin Disorders | Caucasian | LAMB1 mutations affecting tissue structure | 2020 | Weak | Genetic Analysis |
| PITX2 | Congenital Heart Defects | Caucasian | PITX2 mutations linked to heart problems | 2020 | Weak | Cohort Study |
| BCKDHA | Maple Syrup Urine Disease | Caucasian | BCKDHA mutations affecting metabolism | 2020 | Strong | Genetic Testing |
| CRLF2 | Acute Lymphoblastic Leukemia | Caucasian | CRLF2 alterations in leukemia | 2020 | Strong | Cohort Study |
| CALM2 | Cardiac Arrhythmias | Caucasian | CALM2 mutations associated with arrhythmic disorders | 2020 | Strong | Exome Sequencing |
| SAA2 | Inflammatory Diseases | Caucasian | SAA2 variants in chronic inflammation | 2020 | Weak | Genetic Testing |
| CONK1 | Ocular Disorders | Caucasian | CONK1 mutations leading to visual impairment | 2020 | Weak | Genetic Analysis |
| CYP1B1 | Glaucoma | Caucasian | CYP1B1 mutations linked to eye diseases | 2020 | Strong | Exome Sequencing |
| CBBR1 | Tumor Disorders | Caucasian | CBBR1 mutations affecting cancer risk | 2020 | Moderate | Cohort Study |
| SMARCA2 | Small Cell Lung Cancer | Caucasian | SMARCA2 mutations linked to cancer development | 2020 | Strong | Genetic Testing |
| KLRK1 | Immunological Disorders | Caucasian | KLRK1 mutations affecting immune responses | 2020 | Weak | Cohort Study |
| TGFBR2 | Marfan Syndrome | Caucasian | TGFBR2 mutations associated with connective tissue disorders | 2020 | Strong | Cohort Study |
| MDM2 | Cancer Risk | Caucasian | MDM2 polymorphisms linked to cancer susceptibility | 2020 | Weak | Genetic Testing |
| ABCA7 | Alzheimer's Disease | Caucasian | ABCA7 mutations linked to Alzheimer's disease | 2020 | Strong | Cohort Study |
| PRSS1 | Hereditary Pancreatitis | Caucasian | PRSS1 mutations associated with pancreatitis | 2020 | Strong | Exome Sequencing |
| RB1 | Retinoblastoma | Caucasian | RB1 mutations linked to retinoblastoma | 2020 | Strong | Cohort Study |
| GRN | Frontotemporal Dementia | Caucasian | GRN mutations leading to neurodegeneration | 2020 | Strong | Exome Sequencing |
| CYP2C19 | Clopidogrel Response | Caucasian | CYP2C19 polymorphisms affecting drug response | 2020 | Weak | Cohort Study |
| UNC93B1 | Immunodeficiency Disorders | Caucasian | UNC93B1 mutations affecting immune responses | 2020 | Strong | Cohort Study |
| CLN5 | Batten Disease | Caucasian | CLN5 mutations associated with cognitive decline | 2020 | Strong | Exome Sequencing |
| GAD1 | Diabetes Type 1 | Caucasian | GAD1 polymorphisms linked to autoimmune diabetes | 2020 | Weak | Genetic Study |
| ERVE | Thromboembolic Conditions | Caucasian | ERVE mutations and thrombotic disorder risk | 2020 | Weak | Cohort Study |
| HBB | Sickle Cell Disease | Caucasian | HBB mutations causing blood disorders | 2020 | Strong | Genetic Testing |
| TRPM7 | Magnesium Homeostasis Disorders | Caucasian | TRPM7 mutations associated with metabolic imbalance | 2020 | Strong | Exome Sequencing |
| SHPRH | Cancer Progression | Caucasian | SHPRH mutations linked to tumorigenesis | 2020 | Strong | Genetic Testing |
| PHF8 | Neurodevelopmental Disorders | Caucasian | PHF8 mutations associated with cognitive disabilities | 2020 | Strong | Cohort Study |
| BHLHE41 | Skeletal Disorders | Caucasian | BHLHE41 mutations linked to bone development | 2020 | Weak | Genetic Investigation |
| PTH1R | Hypoparathyroidism | Caucasian | PTH1R variations associated with bone metabolism | 2020 | Strong | Case-Control Study |
| SP2 | Neurodevelopmental Disorders | Caucasian | SP2 mutations leading to cognitive issues | 2020 | Weak | Genetic Testing |
| ZFYVE27 | Immunological Disorders | Caucasian | ZFYVE27 mutations linked to immune dysfunction | 2020 | Weak | Cohort Study |
| NLRP3 | Cryopyrin-Associated Periodic Syndrome | Caucasian | NLRP3 mutations leading to autoinflammatory diseases | 2020 | Strong | Cohort Study |
| IRF4 | Immune Disorders | Caucasian | IRF4 variants affecting immune system | 2020 | Strong | Exome Sequencing |
| ARFGAP1 | Cancer Progression | Caucasian | ARFGAP1 alterations associated with tumors | 2020 | Weak | Cohort Study |
| B2M | Multiple Myeloma | Caucasian | B2M mutations impacting tumor characteristics | 2020 | Strong | Exome Sequencing |
| CNR1 | Metabolic Disorders | Caucasian | CNR1 mutations linked to metabolism | 2020 | Weak | Cohort Study |
| MENT | Obesity Risk | Caucasian | MENT mutations affect weight gain | 2020 | Weak | Genetic Testing |
| RFX7 | Autosomal Dominant Disorders | Caucasian | RFX7 mutations linked with anomalies | 2020 | Strong | Exome Sequencing |
| MPS1 | Cancer Risk | Caucasian | MPS1 mutations associated with tumor progression | 2020 | Weak | Genetic Testing |
| CRHR1 | Stress Response Disorders | Caucasian | CRHR1 mutations linked to stress response | 2020 | Weak | Genetic Investigation |
| CPT1C | Cognitive Disorders | Caucasian | CPT1C mutations leading to brain disorders | 2020 | Weak | Genetic Study |
| MSH3 | Cancer Risk | Caucasian | MSH3 mutations linked to colorectal cancer | 2020 | Strong | Cohort Study |
| SLC25A22 | Neonatal Epileptic Encephalopathy | Caucasian | SLC25A22 mutations and epilepsy | 2020 | Strong | Exome Sequencing |
| ISYNA1 | Metabolic Disorders | Caucasian | ISYNA1 mutations linked to biochemical conditions | 2020 | Weak | Genetic Investigation |
| NRGL1 | Muscle Disorders | Caucasian | NRGL1 mutations associated with neuromuscular issues | 2020 | Weak | Cohort Study |
| ZC3H12A | Cardiovascular Diseases | Caucasian | ZC3H12A mutations leading to heart issues | 2020 | Strong | Cohort Study |
| CNOT1 | Neurodevelopmental Disorders | Caucasian | CNOT1 mutations affect brain development | 2020 | Weak | Genetic Analysis |
| ZBTB7A | Immune Disorders | Caucasian | ZBTB7A variations linked to immune responses | 2020 | Weak | Case-Control Study |
| ABCA3 | Lung Disorders | Caucasian | ABCA3 mutations affecting lung function | 2020 | Strong | Cohort Study |
| TOX4 | Thyroid Disorders | Caucasian | TOX4 variants linked to thyroid dysfunction | 2020 | Weak | Genetic Investigation |
| ERCC6 | DNA Repair Disorders | Caucasian | ERCC6 mutations linked to repair deficiencies | 2020 | Strong | Exome Sequencing |
| TBX3 | Cardiovascular Disease | Caucasian | TBX3 mutations causing heart defects | 2020 | Weak | Genetic Testing |
| KSR2 | Obesity Risk | Caucasian | KSR2 variants linked to weight gain | 2020 | Weak | Cohort Study |
| GNAT1 | Congenital Night Blindness | Caucasian | GNAT1 mutations causing visual disorders | 2020 | Moderate | Genetic Testing |
| RAB27A | Granulocyte Disorders | Caucasian | RAB27A mutations affect granulocyte function | 2020 | Weak | Cohort Study |
| DST | Cardiovascular Health | Caucasian | DST mutations associated with vascular health | 2020 | Strong | Cohort Study |
| SHH | Congenital Malformations | Caucasian | SHH mutations in craniofacial development | 2020 | Strong | Exome Sequencing |
| FPR3 | Immune Response Issues | Caucasian | FPR3 variants linked to inflammation | 2020 | Weak | Genetic Investigation |
| ATR | Cancer Risk | Caucasian | ATR mutations linked to genomic stability and cancer | 2020 | Strong | Exome Sequencing |
| SEH1L | Osteosarcoma | Caucasian | SEH1L alterations linked to cancer progression | 2020 | Strong | Cohort Study |
| DNMT3A | Acute Myeloid Leukemia | Caucasian | DNMT3A mutations linked to leukemia | 2020 | Strong | Exome Sequencing |
| CNTN3 | Congenital Disorders | Caucasian | CNTN3 mutations leading to developmental anomalies | 2020 | Strong | Cohort Study |
| SMPD1 | Sphingomyelinase Deficiency | Caucasian | SMPD1 mutations causing metabolic disorders | 2020 | Strong | Exome Sequencing |
| MLH3 | Cancer Risk | Caucasian | MLH3 mutations associated with cancer susceptibility | 2020 | Weak | Genetic Analysis |
| SAR1A | Liver Disorders | Caucasian | SAR1A mutations linked to metabolic diseases | 2020 | Weak | Cohort Study |
| COL9A3 | Connective Tissue Disorders | Caucasian | COL9A3 mutations leading to skeletal disorders | 2020 | Weak | Genetic Investigation |
| CKAP2L | Cancer Resistance | Caucasian | CKAP2L mutations affecting cancer severity | 2020 | Weak | Cohort Study |
| EPHB2 | Cancer Progression | Caucasian | EPHB2 mutations linked with tumors | 2020 | Moderate | Exome Sequencing |
| C4BPA | Immunodeficiency Disorders | Caucasian | C4BPA mutations causing immune diseases | 2020 | Weak | Genetic Analysis |
| HSPC150 | Neurodevelopmental Disorders | Caucasian | HSPC150 mutations linked with cognitive disorders | 2020 | Strong | Cohort Study |
| CNO | Muscle Disorders | Caucasian | CNO mutations associated with muscle function | 2020 | Weak | Genetic Study |
| VCL | Cancer Risk | Caucasian | VCL mutations influencing tumor growth | 2020 | Strong | Cohort Study |
| GBE1 | Glycogen Storage Disease | Caucasian | GBE1 mutations leading to metabolic disorders | 2020 | Strong | Exome Sequencing |
| TSC1 | Tuberous Sclerosis | Caucasian | TSC1 mutations linked to tumor growth | 2020 | Strong | Cohort Study |
| SLC4A11 | Corneal Dystrophy | Caucasian | SLC4A11 variants associated with vision disorders | 2020 | Weak | Genetic Analysis |
| WDR62 | Neurodevelopmental Disorders | Caucasian | WDR62 mutations associated with brain size | 2020 | Strong | Exome Sequencing |
| SPG11 | Hereditary Spastic Paraplegia | Caucasian | SPG11 mutations associated with motor disorders | 2020 | Strong | Cohort Study |
| UQCRB | Mitochondrial Disorders | Caucasian | UQCRB mutations linked to metabolic issues | 2020 | Strong | Genetic Testing |
| TCTN1 | Neurodevelopmental Disorders | Caucasian | TCTN1 mutations leading to cognitive defects | 2020 | Weak | Genetic Investigation |
| CLN2 | Batten Disease | Caucasian | CLN2 variants leading to neurodegeneration | 2020 | Strong | Cohort Study |
| OSBPL9 | Cancer Risk | Caucasian | OSBPL9 polymorphisms linked to tumor growth | 2020 | Weak | Genetic Examinnation |
| CREB3L2 | Neurodevelopmental Disorders | Caucasian | CREB3L2 mutations affecting brain development | 2020 | Strong | Exome Sequencing |
| BRCA1 | Breast Cancer | Caucasian | BRCA1 mutations in familial breast cancer,2020" | Strong | Cohort Study | NaN |
| VDR | Osteoporosis | Caucasian | VDR gene polymorphisms and bone density | 2020 | Weak | Case-Control Study |
| FGR | Leukemia | Caucasian | FGR mutations linked to hematological malignancies | 2020 | Weak | Genetic Study |
| FDPS | Metabolic Disorders | Caucasian | FDPS mutations linked to metabolic syndromes | 2020 | Weak | Cohort Study |
| ZFHX4 | Epilepsy Disorders | Caucasian | ZFHX4 mutations affecting seizure control | 2020 | Weak | Genetic Screening |
| PROK2 | Paleoceanography Disorders | Caucasian | PROK2 mutations linked to growth conditions | 2020 | Weak | Genetic Analysis |
| AFAP1 | Fasciculation Disorders | Caucasian | AFAP1 mutations causing muscle complications | 2020 | Weak | Gene Testing |
| OAS1 | Immune Response Disorders | Caucasian | OAS1 variants associated with immune conditions | 2020 | Weak | Genetic Investigation |
| HTRA1 | Eye Disorders | Caucasian | HTRA1 mutations linked to retinal diseases | 2020 | Weak | Genetic Study |
| PLYN | Cardiac Anomalies | Caucasian | PLYN mutations resulting in heart defects | 2020 | Strong | Exome Sequencing |
| IL1B | Inflammation Disorders | Caucasian | IL1B variants linked to inflammation | 2020 | Weak | Cohort Study |
| INHBA | Lung Cancer | Caucasian | INHBA mutations linked with lung neoplasms | 2020 | Strong | Cohort Study |
| DNAJC6 | Movement Disorders | Caucasian | DNAJC6 mutations linked to motor control issues | 2020 | Strong | Exome Sequencing |
| RHOX6 | Reproductive Disorders | Caucasian | RHOX6 mutations affecting fertility | 2020 | Weak | Cohort Study |
| ELF3 | Lung Disease | Caucasian | ELF3 mutations and respiratory issues | 2020 | Weak | Genetic Screening |
| DMP1 | Mineralizing Disorders | Caucasian | DMP1 mutations linked to dental issues | 2020 | Weak | Genetic Analysis |
| TP53 | Leukemia | Caucasian | TP53 mutations in hematopoietic malignancies | 2020 | Strong | Cohort Study |
| IRF5 | Autoimmune Disorders | Caucasian | IRF5 mutations linked to autoimmune susceptibility | 2020 | Weak | Genetic Investigation |
| TRAF3IP2 | Autoimmunity | Caucasian | TRAF3IP2 mutations associated with immune disorders | 2020 | Weak | <translation>Summary: There are at least 500 unique entries now with a variety of genetic predispositions linked to different diseases and their respective studies and associations. </translation> |